glp-1 from china approves first home-grown weight loss drug, rivaling Ozempic | Yanzhong Huang posted on the topic China Approval of Ecnoglutide Expands

Drug interactions and safety considerations GLP-1 medications interact with several common drugs and supplements

The company is also launching a pen-device version but has not disclosed pricing

Skaggs, L., Heizler, A., Kalscheur, D., Miles, A

Clinical Trial Comparisons Semaglutide (STEP program): The STEP 1 trial demonstrated a mean weight reduction of approximately 14.9% from baseline over 68 weeks with semaglutide 2.4mg weekly

Vasodilatory effect Studies showed that GIPR and GLP1R are present in the smooth muscle cells and endothelial arterioles and may have a cardioprotective effect due to endothelium-dependent vasodilation [105]

Among these, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) coagonists draw much attention because these agents showed potent weight lowering efficacy